Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010014/S118

Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings

Biomet Manufacturing Corp · Decision date Sep 1, 2026

MEDTECHLEDGER EXPLANATIONP010014/S118

What did the FDA decide?

The FDA record for P010014/S118, dated 2026-09-01, describes a 30-Day Notice for a process change in the manufacturer, sterilizer, packager or supplier category. The reported change is an additional supplier of tantalum balls used during manufacturing of Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings at the Zimmer Inc., Warsaw, Indiana facility. The device category listed is a semi-constrained, metal/polymer, mobile-bearing unicompartmental femorotibial knee prosthesis (product code NRA), with Biomet Manufacturing Corp as applicant.

Read as a supplement to PMA P010014, this notice concerns a manufacturing input and does not represent a new approval of the whole knee system or an original PMA. The source states the supplier addition as its reported purpose; the record does not establish independent proof of safety or clinical effectiveness, and it gives no detail on the tantalum balls' specifications, qualification testing or supplier identity.

FDA approval order statement

an additional supplier of tantalum balls used during manufacturing of Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings at the Zimmer Inc., Warsaw, Indiana facility
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Sep 1, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P010014/S118
Regulatory pathway
PMA supplement
Product code
NRA
Decision code
OK30
Decision date
Sep 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing.

Product code
NRA
FDA device class
3

For the original device and its historical approval scope, see PMA P010014. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010014 · Original PMA

    OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM

  2. P010014/S118 received

    Application receipt date recorded by FDA.

  3. P010014/S118 · FDA decision

    30-Day Notice

  4. P010014/S119 · Related supplement

    Cementless Oxford Partial Knee System

  5. P010014/S120 · Related supplement

    Oxford Partial Knee System

Timeline entries are records held by MedtechLedger for P010014. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010014

Product / regulatory recordCompanyPathwayDecision dateSource
Biomet Manufacturing CorpPMA approvalApr 21, 2004FDA
Biomet Manufacturing CorpPMA supplementOct 6, 2026FDA
Biomet Manufacturing CorpPMA supplementOct 26, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biomet Manufacturing Corp

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
56 E. Bell Dr.,, P.O. Box 587, Warsaw, IN, 46581

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records